Open AccessEfficacy of reduced dose melphalan conditioning for multiple myeloma patients undergoing autologous stem cell transplantation: in the era of combined induction with novel agents
Author(s) -
Bahar Uncu Ulu,
Mehmet Bakırtaş,
Tuğçe Nur Yiğenoğlu,
Semih Başçı,
Jale Yıldız,
Derya Şahin,
Tahir Darçın,
Alparslan Merdin,
Hikmetullah Batgi,
Dicle İskender,
Nuran Ahü Baysal,
Sinan DAL,
Merih KIZIL ÇAKIR,
Fevzi Altuntaş
Publication year - 2021
Publication title -
journal of health sciences and medicine
Language(s) - English
Resource type - Journals
ISSN - 2636-8579
DOI - 10.32322/jhsm.868279
Subject(s) - melphalan , medicine , multiple myeloma , bortezomib , autologous stem cell transplantation , oncology , conditioning regimen , regimen , transplantation , stem cell , urology , surgery , gastroenterology , hematopoietic stem cell transplantation , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom